Novartis Ag (NVSEF) Current Taxes (2009 - 2025)

Novartis Ag has disclosed Current Taxes across 15 years of filings, most recently posting $2.0 billion for Q4 2025.

• Current Taxes for Q4 2025 came in at $2.0 billion, up 23.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 23.14% YoY), and the FY2025 annual result was $2.0 billion, up 23.14% from the prior year.
• Current Taxes came in at $2.0 billion for Q4 2025 at Novartis Ag, down from $2.8 billion in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $2.8 billion in Q2 2025 to a low of -$391.0 million in Q1 2021.
• The 5-year median for Current Taxes is $2.2 billion (2021), against an average of $1.9 billion.
• Across the five-year window, Current Taxes surged 663.18% in 2021 and fell 27.61% in 2024, its largest moves.
• Novartis Ag's Current Taxes stood at $2.4 billion in 2021, then grew by 4.89% to $2.5 billion in 2022, then slipped by 25.27% to $1.9 billion in 2023, then dropped by 15.53% to $1.6 billion in 2024, then rose by 23.14% to $2.0 billion in 2025.
• The last three Current Taxes figures came in at $2.0 billion (Q4 2025), $2.8 billion (Q2 2025), and $1.6 billion (Q4 2024), per Business Quant data.